{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T02:06:52Z","timestamp":1777860412618,"version":"3.51.4"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2010,9,15]],"date-time":"2010-09-15T00:00:00Z","timestamp":1284508800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2011,2]]},"DOI":"10.1007\/s10067-010-1566-4","type":"journal-article","created":{"date-parts":[[2010,9,14]],"date-time":"2010-09-14T04:26:42Z","timestamp":1284438402000},"page":"157-163","source":"Crossref","is-referenced-by-count":23,"title":["Evaluation of current therapeutic strategies in Beh\u00e7et\u2019s disease"],"prefix":"10.1007","volume":"30","author":[{"given":"Iliana","family":"Alexoudi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Violetta","family":"Kapsimali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aristides","family":"Vaiopoulos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meletios","family":"Kanakis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George","family":"Vaiopoulos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,9,15]]},"reference":[{"key":"1566_CR1","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1007\/s00403-009-0990-2","volume":"301","author":"E Alpsoy","year":"2009","unstructured":"Alpsoy E, Akman A (2009) Beh\u00e7et\u2019s disease: an algorithmic approach to its treatment. Arch Dermatol Res 301:693\u2013702","journal-title":"Arch Dermatol Res"},{"key":"1566_CR2","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1002\/art.10815","volume":"48","author":"T Ahmad","year":"2003","unstructured":"Ahmad T, Wallace GR, James T et al (2003) Mapping the HLA association in Beh\u00e7et\u2019s disease: a role for tumor necrosis factor polymorphisms? Arth Rheum 48:807\u2013813","journal-title":"Arth Rheum"},{"key":"1566_CR3","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1024\/0301-1526.32.3.149","volume":"32","author":"H Ceyran","year":"2003","unstructured":"Ceyran H, Akcali Y, Kahraman C (2003) Surgical treatment of vasculo-Beh\u00e7et\u2019s disease. A review of patients with concomitant multiple aneurysms and venous lesions. Vasa 32:149\u2013153","journal-title":"Vasa"},{"key":"1566_CR4","doi-asserted-by":"crossref","unstructured":"Kapsimali V, Kanakis M, Vaiopoulos G, et al (2010) Etiopathogenesis of Beh\u00e7et\u2019s disease with emphasis on the role of immunological aberrations. Clin Rheumatol (in press)","DOI":"10.1007\/s10067-010-1491-6"},{"key":"1566_CR5","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s11926-008-0057-y","volume":"10","author":"KT Calamia","year":"2008","unstructured":"Calamia KT, Kaklamanis PG (2008) Beh\u00e7et\u2019s disease: recent advances in early diagnosis and effective treatment. Curr Rheumatol Rep 10:349\u2013355","journal-title":"Curr Rheumatol Rep"},{"key":"1566_CR6","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.2165\/00003495-200767140-00004","volume":"67","author":"A Gul","year":"2007","unstructured":"Gul A (2007) Standard and novel therapeutic approaches to Beh\u00e7et\u2019s disease. Drugs 67:2013\u20132022","journal-title":"Drugs"},{"key":"1566_CR7","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S0140-6736(01)05497-6","volume":"358","author":"PP Sfikakis","year":"2001","unstructured":"Sfikakis PP, Theodossiadis PG, Katsiari CG et al (2001) Effect of infliximab on sight-threatening panuveitis in Beh\u00e7et\u2019s disease. Lancet 358:295\u2013296","journal-title":"Lancet"},{"key":"1566_CR8","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1001\/archdermatol.2008.591","volume":"145","author":"CB Lynde","year":"2009","unstructured":"Lynde CB, Bruce AS, Rogers RS 3rd (2009) Successful treatment of complex aphthosis with colchicine and dapsone. Arch Dermatol 145:273\u2013276","journal-title":"Arch Dermatol"},{"key":"1566_CR9","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1002\/jlb.62.6.827","volume":"62","author":"SM Debol","year":"1997","unstructured":"Debol SM, Herron MJ, Nelson RD (1997) Anti-inflammatory action of dapsone: inhibition of neutrophil adherence is associated with inhibition of chemoattractant-induced signal transduction. J Leukoc Biol 62:827\u2013836","journal-title":"J Leukoc Biol"},{"key":"1566_CR10","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1053\/sarh.2001.19819","volume":"30","author":"P Kaklamanis","year":"2001","unstructured":"Kaklamanis P, Kaklamani V (2001) Treatment of Beh\u00e7et\u2019s disease\u2014an update. Semin Arth Rheum 30:299\u2013312","journal-title":"Semin Arth Rheum"},{"key":"1566_CR11","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1136\/ard.2008.087957","volume":"68","author":"G Hatemi","year":"2009","unstructured":"Hatemi G, Silman A, Bang D et al (2009) Management of Behcet disease: a systematic literature review for the European League Against Rheumatism evidence-based recommendations for the management of Behcet disease. Ann Rheum Dis 68:1528","journal-title":"Ann Rheum Dis"},{"key":"1566_CR12","first-page":"125","volume":"31","author":"E Seyahi","year":"2006","unstructured":"Seyahi E, Fresko I, Yazici H et al (2006) The management of Behcet syndrome. Acta Rheum Port 31:125\u2013131","journal-title":"Acta Rheum Port"},{"key":"1566_CR13","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1097\/01.rhu.0000249894.03016.de","volume":"12","author":"P Lin","year":"2006","unstructured":"Lin P, Liang G (2006) Beh\u00e7et disease: recommendation for clinical management of mucocutaneous lesions. J Clin Rheumatol 12:282\u2013286","journal-title":"J Clin Rheumatol"},{"key":"1566_CR14","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1007\/s10067-004-1015-3","volume":"24","author":"F Duygulu","year":"2005","unstructured":"Duygulu F, Evereklioglu MM et al (2005) Synovial nitric oxide concentrations are increased and correlated with serum levels in patients with active Beh\u00e7et\u2019s disease: a pilot study. Clin Rheumatol 24:324\u2013330","journal-title":"Clin Rheumatol"},{"key":"1566_CR15","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1093\/rheumatology\/kem034","volume":"46","author":"PP Sfikakis","year":"2007","unstructured":"Sfikakis PP, Markomichelakis N, Alpsoy E et al (2007) Anti-TNF therapy in the management of Behcet\u2019s disease\u2014review and basis for recommendations. Rheumatology (Oxford) 46:736\u2013741","journal-title":"Rheumatology (Oxford)"},{"key":"1566_CR16","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s102270000022","volume":"5","author":"QH D\u00e9 Tran","year":"2001","unstructured":"D\u00e9 Tran QH, Guay E, Chartier S, Tousignant J (2001) Tacrolimus in dermatology. J Cutan Med Surg 5:329\u2013335","journal-title":"J Cutan Med Surg"},{"key":"1566_CR17","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s004030050179","volume":"289","author":"I Bruynzeel","year":"1997","unstructured":"Bruynzeel I, Van Der Raaij LM, Willemze R, Stoof TJ (1997) Pentoxifylline inhibits human T-cell adhesion to dermal endothelial cells. Arch Dermatol Res 289:189\u2013193","journal-title":"Arch Dermatol Res"},{"key":"1566_CR18","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/0192-0561(95)00096-8","volume":"17","author":"JO Funk","year":"1995","unstructured":"Funk JO, Ernst M, Schonharting MM, Zabel P (1995) Pentoxifylline exerts synergistic immunomodulatory effects in combination with dexamethasone or cyclosporin A. Int J Immunopharmacol 17:1007\u20131016","journal-title":"Int J Immunopharmacol"},{"key":"1566_CR19","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1001\/archderm.134.8.1010","volume":"134","author":"CC Zouboulis","year":"1998","unstructured":"Zouboulis CC, Orfanos CE (1998) Treatment of Adamantiades-Beh\u00e7et disease with systemic interferon alfa. Arch Dermatol 134:1010\u20131016","journal-title":"Arch Dermatol"},{"key":"1566_CR20","doi-asserted-by":"crossref","first-page":"979","DOI":"10.3748\/wjg.v12.i6.979","volume":"12","author":"T Nakamura","year":"2006","unstructured":"Nakamura T, Yagi H, Kurachi K, Konno H (2006) Intestinal Behcet\u2019s disease with pyoderma gangrenosum: a case report. World J Gastroenterol 12:979\u2013981","journal-title":"World J Gastroenterol"},{"key":"1566_CR21","doi-asserted-by":"crossref","first-page":"3211","DOI":"10.1517\/14656560802457749","volume":"9","author":"I Fresko","year":"2008","unstructured":"Fresko I, Yazici H (2008) Treatment strategies for Beh\u00e7et\u2019s disease. Expert Opin Pharmacother 9:3211\u20133219","journal-title":"Expert Opin Pharmacother"},{"key":"1566_CR22","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1007\/BF02235590","volume":"43","author":"IJ Choi","year":"2000","unstructured":"Choi IJ, Kim JS, Cha SD et al (2000) Long-term clinical course and prognostic factors in intestinal Beh\u00e7et\u2019s disease. Dis Colon Rectum 43:692\u2013700","journal-title":"Dis Colon Rectum"},{"key":"1566_CR23","doi-asserted-by":"crossref","first-page":"455","DOI":"10.3349\/ymj.1997.38.6.455","volume":"38","author":"KS Lee","year":"1997","unstructured":"Lee KS, Kim SJ, Lee BC et al (1997) Surgical treatment of intestinal Beh\u00e7et\u2019s disease. Yonsei Med J 38:455\u2013460","journal-title":"Yonsei Med J"},{"key":"1566_CR24","first-page":"60","volume":"53","author":"M Kurata","year":"2006","unstructured":"Kurata M, Nozue M, Seino K et al (2006) Indications for surgery in intestinal Beh\u00e7et\u2019s disease. Hepatogastroenterology 53:60\u201363","journal-title":"Hepatogastroenterology"},{"key":"1566_CR25","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.jaad.2005.10.004","volume":"54","author":"AN Sapadin","year":"2006","unstructured":"Sapadin AN, Fleischmajer R (2006) Tetracyclines: nonantibiotic properties and their clinical implications. J Am Acad Dermatol 54:258\u2013265","journal-title":"J Am Acad Dermatol"},{"key":"1566_CR26","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.preteyeres.2007.09.002","volume":"27","author":"CM Deuter","year":"2008","unstructured":"Deuter CM, Kotter I, Wallace GR et al (2008) Beh\u00e7et\u2019s disease: ocular effects and treatment. Prog Retin Eye Res 27:111\u2013136","journal-title":"Prog Retin Eye Res"},{"key":"1566_CR27","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/j.ajo.2008.06.019","volume":"146","author":"RO Ka\u00e7maz","year":"2008","unstructured":"Ka\u00e7maz RO, Kempen JH, Newcomb C et al (2008) Systemic immunosuppressive therapy for eye diseases cohort study group. Ocular inflammation in Beh\u00e7et disease: incidence of ocular complications and of loss of visual acuity. Am J Ophthalmol 146:828\u2013836","journal-title":"Am J Ophthalmol"},{"key":"1566_CR28","doi-asserted-by":"crossref","first-page":"2478","DOI":"10.1002\/art.21231","volume":"52","author":"I Tugal-Tutkun","year":"2005","unstructured":"Tugal-Tutkun I, Mudun A, Urgancioglu M et al (2005) Efficacy of Infliximab in the treatment of uveitis that is resistant to treatment with the combination of azathioprine, cyclosporine and corticosteroids in Behcet disease: an open-label trial. Arthritis Rheum 52:2478\u20132484","journal-title":"Arthritis Rheum"},{"key":"1566_CR29","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1056\/NEJM199002013220501","volume":"322","author":"H Yazici","year":"1990","unstructured":"Yazici H, Pazarli H, Barnes CG et al (1990) A controlled trial of azathioprine in Beh\u00e7et\u2019s syndrome. N Engl J Med 322:281\u2013285","journal-title":"N Engl J Med"},{"issue":"Suppl","key":"1566_CR30","first-page":"S84","volume":"26","author":"G Akman-Demir","year":"2008","unstructured":"Akman-Demir G, Ayranci O, Kurtuncu M et al (2008) Cyclosporine for Beh\u00e7et\u2019s uveitis: is it associated with an increased risk of neurological involvement? Clin Exp Rheumatol 26(Suppl):S84\u2013S90","journal-title":"Clin Exp Rheumatol"},{"key":"1566_CR31","first-page":"896","volume":"35","author":"L Krause","year":"2008","unstructured":"Krause L, Altenburg A, Pleyer U et al (2008) Longterm visual prognosis of patients with ocular Adamantiades-Beh\u00e7et\u2019s disease treated with interferon-alpha-2a. J Rheumatol 35:896\u2013903","journal-title":"J Rheumatol"},{"key":"1566_CR32","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1007\/s10384-005-0307-8","volume":"50","author":"I Tugal-Tutkun","year":"2006","unstructured":"Tugal-Tutkun I, Onal S, Altan-Yaycioglu R et al (2006) Neovascularization of the optic disc in Beh\u00e7et\u2019s disease. Jpn J Ophthalmol 50:256\u2013265","journal-title":"Jpn J Ophthalmol"},{"issue":"Suppl 2","key":"1566_CR33","doi-asserted-by":"crossref","first-page":"ii51","DOI":"10.1136\/ard.61.suppl_2.ii51","volume":"61","author":"PP Sfikakis","year":"2002","unstructured":"Sfikakis PP (2002) Beh\u00e7et\u2019s disease: a new target for anti-tumour necrosis factor treatment. Ann Rheum Dis 61(Suppl 2):ii51\u2013ii53","journal-title":"Ann Rheum Dis"},{"issue":"Suppl","key":"1566_CR34","first-page":"S65","volume":"25","author":"A Elezoglou","year":"2007","unstructured":"Elezoglou A, Kafasi N, Kaklamanis PH et al (2007) Infliximab treatment-induced formation of autoantibodies is common in Beh\u00e7et\u2019s disease. Clin Exp Rheumatol 25(Suppl):S65\u2013S69","journal-title":"Clin Exp Rheumatol"},{"key":"1566_CR35","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1007\/s00417-007-0577-6","volume":"245","author":"L Krause","year":"2007","unstructured":"Krause L, Altenburg A, Bechrakis NE et al (2007) Intraocular surgery under systemic interferon-alpha therapy in ocular Adamantiades-Beh\u00e7et\u2019s disease. Graefes Arch Clin Exp Ophthalmol 245:1617\u20131621","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"1566_CR36","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1177\/112067210701700207","volume":"17","author":"U Elgin","year":"2007","unstructured":"Elgin U, Berker N, Batman A, Soykan E (2007) Nd:YAG laser iridotomy in the management of secondary glaucoma associated with Beh\u00e7et\u2019s disease. Eur J Ophthalmol 17:191\u2013195","journal-title":"Eur J Ophthalmol"},{"key":"1566_CR37","doi-asserted-by":"crossref","first-page":"292","DOI":"10.3928\/1542-8877-20050701-07","volume":"36","author":"Y Sullu","year":"2005","unstructured":"Sullu Y, Alotaiby H, Beden U, Erkan D (2005) Pars plana vitrectomy for ocular complications of Beh\u00e7et\u2019s disease. Ophthalmic Surg Lasers Imaging 36:292\u2013297","journal-title":"Ophthalmic Surg Lasers Imaging"},{"key":"1566_CR38","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1023\/A:1022587012611","volume":"24","author":"M Soylu","year":"2001","unstructured":"Soylu M, Demircan N, Pelit A (2001) Pars plana vitrectomy in ocular Beh\u00e7et\u2019s disease. Int Ophthalmol 24:219\u2013223","journal-title":"Int Ophthalmol"},{"key":"1566_CR39","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/j.echo.2009.07.025","volume":"22","author":"JK Han","year":"2009","unstructured":"Han JK, Kim HK, Kim YJ et al (2009) Beh\u00e7et\u2019s disease as a frequently unrecognized cause of aortic regurgitation: suggestive and misleading echocardiography findings. J Am Soc Echocardiogr 22:1269\u20131274","journal-title":"J Am Soc Echocardiogr"},{"key":"1566_CR40","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1111\/j.1540-8191.2008.00607.x","volume":"23","author":"M Marzban","year":"2008","unstructured":"Marzban M, Mandegar MH, Karimi A et al (2008) Cardiac and great vessel involvement in \u201cBehcet\u2019s disease\u201d. J Card Surg 23:765\u2013768","journal-title":"J Card Surg"},{"key":"1566_CR41","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1093\/eurheartj\/ehn608","volume":"30","author":"M Imazio","year":"2009","unstructured":"Imazio M, Brucato A, Trinchero R et al (2009) Colchicine for pericarditis: hype or hope? Eur Heart J 30:532\u2013539","journal-title":"Eur Heart J"},{"key":"1566_CR42","doi-asserted-by":"crossref","first-page":"903","DOI":"10.2169\/internalmedicine.45.1582","volume":"45","author":"K Arishiro","year":"2006","unstructured":"Arishiro K, Nariyama J, Hoshiga M et al (2006) Vascular Beh\u00e7et\u2019s disease with coronary artery aneurysm. Intern Med 45:903\u2013907","journal-title":"Intern Med"},{"key":"1566_CR43","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s00431-009-1040-y","volume":"169","author":"S Ozen","year":"2010","unstructured":"Ozen S, Bilginer Y, Besbas N et al (2010) Beh\u00e7et disease: treatment of vascular involvement in children. Eur J Pediatr 169:427\u2013430","journal-title":"Eur J Pediatr"},{"key":"1566_CR44","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1111\/j.1365-2133.2008.08679.x","volume":"159","author":"SH Oh","year":"2008","unstructured":"Oh SH, Lee JH, Shin JU, Bang D (2008) Dermatological features in Beh\u00e7et disease-associated vena cava obstruction. Br J Dermatol 159:555\u2013560","journal-title":"Br J Dermatol"},{"key":"1566_CR45","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.avsg.2006.12.004","volume":"21","author":"U Alpagut","year":"2007","unstructured":"Alpagut U, Ugurlucan M, Dayioglu E (2007) Major arterial involvement and review of Beh\u00e7et\u2019s disease. Ann Vasc Surg 21:232\u2013239","journal-title":"Ann Vasc Surg"},{"key":"1566_CR46","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/j.jvs.2008.09.055","volume":"49","author":"H Abdul-Hussien","year":"2009","unstructured":"Abdul-Hussien H, Hanemaaijer R, Verheijen JH et al (2009) Doxycycline therapy for abdominal aneurysm: improved proteolytic balance through reduced neutrophil content. J Vasc Surg 49:741\u2013749","journal-title":"J Vasc Surg"},{"key":"1566_CR47","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1007\/s00415-009-0145-6","volume":"256","author":"A Siva","year":"2009","unstructured":"Siva A, Saip S (2009) The spectrum of nervous system involvement in Beh\u00e7et\u2019s syndrome and its differential diagnosis. J Neurol 256:513\u2013529","journal-title":"J Neurol"},{"key":"1566_CR48","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1586\/ern.09.11","volume":"9","author":"A Borhani Haghighi","year":"2009","unstructured":"Borhani Haghighi A (2009) Treatment of neuro-Beh\u00e7et\u2019s disease: an update. Expert Rev Neurother 9:565\u2013574","journal-title":"Expert Rev Neurother"},{"key":"1566_CR49","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/s10067-008-1070-2","volume":"28","author":"T Gono","year":"2009","unstructured":"Gono T, Murata M, Kawaguchi Y et al (2009) Successful treatment for sympathetic storms in a patient with neuro-Beh\u00e7et\u2019s disease. Clin Rheumatol 28:357\u2013359","journal-title":"Clin Rheumatol"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-010-1566-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10067-010-1566-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-010-1566-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,4]],"date-time":"2019-06-04T18:21:14Z","timestamp":1559672474000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10067-010-1566-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,9,15]]},"references-count":49,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,2]]}},"alternative-id":["1566"],"URL":"https:\/\/doi.org\/10.1007\/s10067-010-1566-4","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,9,15]]}}}